ArticleFrontiers in pharmacology2024

Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5.

Zhaoyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.